Vidofludimus

Cat. No. M4876

All AbMole products are for research use only, cannot be used for human consumption.

Synonym:

SC12267, 4SC-101

Size	Price	Availability
10mM*1mL in DMSO	USD 60 USD60	In stock
1mg	USD 40 USD40	In stock
5mg	USD 75 USD75	In stock
10mg	USD 120 USD120	In stock
25mg	USD 240 USD240	In stock
50mg	USD 370 USD370	In stock

Free Delivery on orders over USD 500 Bulk Inquiry?

Vidofludimus (4SC-101; SC12267) is an immunosuppressant that inhibits DHODH and inhibits il-17 secretion without affecting lymphocyte proliferation.

Molecular Weight	355.36
Formula	C20H18FNO4
CAS Number	717824-30-1
Solubility (25°C)	DMSO 100 mg/mL
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related DHODH Products
DHODH-IN-13 DHODH-IN-13 is a hydroxyfurazan analog of A771726 and a dihydroorotic acid dehydrogenase (DHODH) inhibitor with an IC50 of 4.3 μM for hepatic DHODH in rats.DHODH-IN-13 can be used in rheumatoid arthritis-related studies.
DHODH-IN-12 DHODH-IN-12 is a Leflunomide derivative and a weak inhibitor of dihydroorotic acid dehydrogenase (DHODH), with a pKa of 5.07.
hDHODH-IN-5 hDHODH-IN-5 is a human dihydroorotic acid dehydrogenase (DHODH) inhibitor with an IC50 of 0.91 μM. hDHODH-IN-7 induces differentiation of acute myeloid leukemia cells.
DHODH-IN-8 DHODH-IN-8 is an inhibitor of human and Plasmodium falciparum dihydroorotic acid dehydrogenase (DHODH) with IC50s of 0.13 μM and 47.4 μM and Ki of 0.016 μM and 5.6 μM, respectively.DHODH-IN-8 exhibits antimalarial activity.
DHODH-IN-14 DHODH-IN-14 is a hydroxyfurazan analog of A771726 and a dihydroorotic acid dehydrogenase (DHODH) inhibitor with an IC50 of 0.49 μM for hepatic DHODH in rats.DHODH-IN-14 can be used in rheumatoid arthritis-related studies.

Catalog